Skip to content

Cap Assisted Colonoscopy for the Detection of Colon Polyps

Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01211132
Enrollment
462
Registered
2010-09-29
Start date
2009-09-30
Completion date
2010-11-30
Last updated
2010-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma, Colon Cancer, Colon Polyps

Keywords

Colon polyps, Adenoma detection, Cap, Standard, Colon Cancer

Brief summary

This simple technique of attaching a transparent cap to the tip of the colonoscope has been evaluated in Japan for improving the detection of polyps and cecal intubation but has not been formally evaluated in the US and other western countries. In one study (19), the polyp detection rate was higher with the transparent cap compared to no cap (49% vs. 39%, p=0.04). Also, the cecal intubation time was shorter with the cap (11.5 min vs 14 min, p=0.008). In a recently published study, a variation of the cap called the transparent retractable extension device was used (21). Overall, the number of adenomas detected were significantly higher with the device compared to without it (205 vs. 150, p=0.04). In an earlier study by Tada et al (22), use of a transparent cap improved the detection rate of lesions per patient (0.86 vs. 0.58) but did not increase the cecal intubation time. Finally, Lee et al (20) used cap assisted colonoscopy in patients with difficult colonoscopy procedure (defined as failure to pass through sigmoid colon after 20 minutes or failure to reach cecum). Using the cap, cecal intubation was achieved in 94% of patients and this proved to be an effective rescue method for failed or difficult colonoscopy. The major appeal of this technique is that it is inexpensive, very practical, and easy to use. Furthermore it is safe and there are no reported complications from this. If found to be effective in increasing the polyp yield it has the potential to being incorporated by busy gastroenterologists in their day to day clinical practice. These features and the preliminary data from Japan merit the evaluation of this promising technique in the US.

Detailed description

The investigators hypothesize that adenoma detection rate will be higher using cap assisted colonoscopy compared to standard colonoscopy. Also, cap assisted colonoscopy will be safe and cecal intubation rate will be similar compared to standard colonoscopy. Specific Aim 1 - To compare the prevalence of adenomas detected by standard colonoscopy and cap assisted colonoscopy. Specific Aim 2 - To compare the number of adenomas detected per subject by standard colonoscopy and cap assisted colonoscopy. Specific aim 3 - To compare the cecal intubation rate, insertion time, withdrawal time and complications of standard colonoscopy and cap assisted colonoscopy.

Interventions

DEVICECap - Transparent retractable extension device.

Attaching a Cap - Transparent retractable extension device.

DEVICEStandard

Without attaching a transparent cap to the tip of colonoscope.

Sponsors

Midwest Biomedical Research Foundation
CollaboratorOTHER
American Society for Gastrointestinal Endoscopy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Referral for screening and/or surveillance colonoscopy and the ability to provide informed consent.

Exclusion criteria

* prior surgical resection of any portion of colon, * prior history of colon cancer, * history of inflammatory bowel disease, * use of anti-platelet agents or anticoagulants that precludes removal of polyps during the procedure, * poor general condition or any other reason to avoid prolonged procedure time * inability to give informed consent, * inadequate bowel preparation. * history of polyposis syndrome or HNPCC,

Design outcomes

Primary

MeasureTime frame
The primary outcome is the prevalence of adenomas in the two groups.2 years

Secondary

MeasureTime frame
The secondary outcomes are the number of adenomas detected per subject, cecal intubation rate, insertion times, withdrawal times and complication rates in the two arms.2 years

Countries

United States

Contacts

Primary ContactDeepthi S Rao, MBBS
Deepthi.Rao@va.gov816-861-4700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026